SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GelTex Pharmaceuticals (GELX)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Silverman who wrote (32)10/24/1997 11:29:00 AM
From: NY0001  Read Replies (2) of 127
 
I will review your posts. Its possible that I got the wrong impression.

It doesn't matter anyway. I am just trying to get information, good or
bad, like everyone else. I appreciate your input.

Question, why aren't you worried about the nutraceutical threat to
pharmaceutical based cholestorol-lowering agents? Rasio Group has a
market cap that is 3 x that of Geltex. Clearly, the market thinks
it is an important aspect for cholestorol lowering technology.

The smaller company I follow, Forbes Medi-Tech, is still at a low
market cap but that is probably because it is still listed on the
VSE and because they only have a Letter of Intent from the food
manufacturer, not a final contract. Once they announce a final contract
and list on Nasdaq I think that they will be looked at as a
comparable for GELX.

What's your rationale for discounting the nutraceutical competition?
I would love to hear your answer. It sounds like you have a feel for this
area of investment. I am just new to biotech but I like it. That is
why I am hedging with multiple investments in an area (cholestorol
lowering agents) rather than betting the farm on just one. I hope they
all win!!!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext